Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Primary pancreatic lymphomas.

Muhammad Wasif Saif1

  • 1Yale University School of Medicine, New Haven, CT 06520, USA. wasif.saif@yale.edu

JOP : Journal of the Pancreas
|May 11, 2006
PubMed
Summary
This summary is machine-generated.

Primary pancreatic lymphomas are rare cancers presenting like pancreatic cancer. Diagnosis via fine-needle aspiration (FNA) and flow cytometry is crucial for non-surgical treatment and better outcomes.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Staged approach to overcome hyperbilirubinemia: tailored chemotherapy in liver metastases-a case report.

Journal of gastrointestinal oncology·2026
Same author

An overview of KRAS-targeting therapies for colorectal cancer in phase I and II development.

Expert opinion on investigational drugs·2026
Same author

PCNA Inhibition Enhances the Antitumor Activity of KRAS-Targeted Therapies in Pancreatic Cancer.

bioRxiv : the preprint server for biology·2025
Same author

Co-targeting KRAS and Exportin1 as an effective therapeutic strategy for KRASG12D mutant pancreatic ductal adenocarcinoma.

bioRxiv : the preprint server for biology·2025
Same author

An Update on Novel Pharmacotherapies for the Treatment of Neuroendocrine Tumors.

International journal of molecular sciences·2025
Same author

XPO1 inhibition in KRAS-mutant cancers: time for clinical trials but how?

Translational lung cancer research·2025
Same journal

Bridging the Gap in Pancreatic Imaging: A New Era of AI-Powered Precision.

JOP : Journal of the pancreas·2025
Same journal

From Screening to Treatment of Pancreatic Cancer: A Comprehensive Review.

JOP : Journal of the pancreas·2021
Same journal

Survival Benefits and Disparities in Adjuvant Radiation Therapy for Patients with Pancreatic Cancer.

JOP : Journal of the pancreas·2021
Same journal

Is There any Survival Benefit of Maintenance Chemotherapy Following Adjuvant Chemotherapy in Patients with Resected Pancreatic Cancer Patients with Post-Surgery Elevated CA 19-9?

JOP : Journal of the pancreas·2020
Same journal

New Developments in the Treatment of Pancreatic Cancer: Highlights from the 44th ASCO Annual Virtual Meeting, May 29-31, 2020.

JOP : Journal of the pancreas·2020
Same journal

Management of Pancreatic Cancer During COVID-19 Pandemic: To Treat or Not to Treat?

JOP : Journal of the pancreas·2020
See all related articles

Area of Science:

  • Oncology
  • Hematology
  • Gastroenterology

Background:

  • Primary pancreatic lymphomas are exceptionally rare malignancies.
  • Clinical presentation often mimics pancreatic head carcinoma, leading to diagnostic challenges.
  • These lymphomas predominantly affect males aged 35-75, presenting with abdominal pain, jaundice, and pancreatitis.

Purpose of the Study:

  • To highlight the diagnostic modalities for primary pancreatic lymphomas.
  • To emphasize the importance of accurate cytopathologic diagnosis for guiding non-surgical treatment.
  • To differentiate primary pancreatic lymphomas from other pancreatic conditions.

Main Methods:

  • Fine-needle aspiration (FNA) for cytomorphologic analysis.
  • Flow cytometry to assess immunoglobulin light chain expression for clonality.

Related Experiment Videos

  • Fluorescence in-situ hybridization (FISH) for lymphoid malignancy diagnosis.
  • Analysis of tumor markers like LDH and beta-2 microglobulin.

    • Main Results:

    • FNA reveals hypercellularity with discohesive cells, round nuclei, prominent nucleoli, mitoses, and karyorrhexis.
    • Flow cytometry demonstrates a monoclonal immunoglobulin light chain pattern, indicative of lymphoma.
    • FNA combined with flow cytometry shows high diagnostic accuracy.
    • FISH aids in diagnosing lymphoid malignancies.
    • Elevated LDH and beta-2 microglobulin serve as diagnostic and prognostic markers.

    Conclusions:

    • Accurate diagnosis of primary pancreatic lymphoma is achievable through FNA and flow cytometry.
    • Non-surgical management, including chemotherapy and radiation, is the primary treatment approach.
    • Primary pancreatic lymphomas have a significantly better prognosis compared to pancreatic adenocarcinoma.